Fundz

Gordonmd® Announces Second Investment In Radiopharmaceutical Biotech Radionetics Oncology

PRIVATEJan 05, 2024

Round Type

Venture

Menlo ParkPharmaceutical Manufacturing

Investors

Gordon Md®Frazier Life Sciences

Description

GordonMD® Global Investments LP, a key investor in groundbreaking healthcare solutions, announced another strategic investment in Radionetics Oncology.

Quick answer

Radionetics Oncology raised an undisclosed amount in a funding round, dated January 5, 2024. Investors: Gordon Md® and Frazier Life Sciences. Radionetics Oncology is based in Menlo Park, California, United States.

How much did Radionetics Oncology raise?
Radionetics Oncology raised an undisclosed amount in a funding round on January 5, 2024.
Who invested in Radionetics Oncology?
Gordon Md® and Frazier Life Sciences are named as investors in this round.
What does Radionetics Oncology do?
Radionetics Oncology is a pharmaceutical company focused on the discovery and development of novel radiotherapeutics for the treatment of a wide range of oncology indications.
Where is Radionetics Oncology based and how big is it?
Radionetics Oncology is based in Menlo Park, California, United States.
Who are the decision-makers at Radionetics Oncology?
Fundz holds 1 contact at Radionetics Oncology. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Pharmaceutical Manufacturing around the same time

Companies in the same sectors as Radionetics Oncology that raised within 45 days of this round, from Fundz verified event records.

  • XORTX Therapeutics raised $2.5M (Seed) on February 19, 2024.
  • COUR Pharmaceuticals raised $105M (Funding Round) on February 11, 2024.
  • DUDE CHEM raised $6.5M (Funding Round) on February 7, 2024.
  • Orexa raised $940K (Seed) on February 2, 2024.
  • COUR Pharmaceuticals raised $105M (Series A) on January 30, 2024.
  • 3Daughters raised $2M (Seed) on January 22, 2024.

Who to call at Radionetics Oncology, and when

A new round usually means Radionetics Oncology is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Radionetics Oncology raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Radionetics Oncology, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Radionetics Oncology. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Radionetics Oncology

Location

70 WILLOW STREET

Menlo Park, California, United States

About

Radionetics Oncology is a pharmaceutical company focused on the discovery and development of novel radiotherapeutics for the treatment of a wide range of oncology indications. The company’s platform technology uses nonpeptide, small molecule targeting to deliver therapeutic radioisotopes to a broad range of cancers by binding selectively to peptide receptors that are selectively expressed on these tumors. This nonpeptide technology addresses many of the significant challenges currently facing peptide and protein targeted radiotherapeutics, particularly in the realm of optimizing drug-like characteristics and manufacturing. The company is rapidly advancing a pipeline of drug candidates to treat a broad range of cancers and is conducting additional drug discovery efforts to identify drug candidates for additional receptor targets in collaboration with Crinetics Pharmaceuticals.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Radionetics Oncology raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Radionetics Oncology's next move

See what Strategic adds

Radionetics Oncology raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.